Cargando…

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma

Virus proliferation involves gene replication inside infected cells and transmission to new target cells. Once positive-strand RNA virus has infected a cell, the viral genome serves as a template for copying (“stay-strategy”) or is packaged into a progeny virion that will be released extracellularly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwanami, Shoya, Kitagawa, Kosaku, Ohashi, Hirofumi, Asai, Yusuke, Shionoya, Kaho, Saso, Wakana, Nishioka, Kazane, Inaba, Hisashi, Nakaoka, Shinji, Wakita, Takaji, Diekmann, Odo, Iwami, Shingo, Watashi, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392214/ https://www.ncbi.nlm.nih.gov/pubmed/32730280 http://dx.doi.org/10.1371/journal.pbio.3000562

Ejemplares similares

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021)

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
por: Iwanami, Shoya, et al.
Publicado: (2021)

Revisiting the guidelines for ending isolation for COVID-19 patients
por: Jeong, Yong Dam, et al.
Publicado: (2021)

A systematic procedure for incorporating separable static heterogeneity into compartmental epidemic models
por: Diekmann, Odo, et al.
Publicado: (2023)

A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture
por: Iwanami, Shoya, et al.
Publicado: (2017)

Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model
por: Ejima, Keisuke, et al.
Publicado: (2021)

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
por: Ohashi, Hirofumi, et al.
Publicado: (2022)

Dealing with the delirium dilemma
por: Polderman, Kees H, et al.
Publicado: (2005)

Estimation of the incubation period of COVID-19 using viral load data
por: Ejima, Keisuke, et al.
Publicado: (2021)

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
por: Watashi, Koichi, et al.
Publicado: (2014)

Monoarticular synovitis of knee: dealing with the dilemma
por: Goyal, Tarun, et al.
Publicado: (2020)

Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives
por: Nishiuchi, Kota, et al.
Publicado: (2021)

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments
por: Akazawa, Daisuke, et al.
Publicado: (2023)

Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors
por: Tatematsu, Daiki, et al.
Publicado: (2023)

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection
por: Kumata, Ryuichi, et al.
Publicado: (2022)

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide
por: Kaneko, Manabu, et al.
Publicado: (2018)

Dealing with Dilemmas: Where Business Analytics Fall Short
por: Buytendijk, Frank
Publicado: (2010)

Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation for analyzing extracellular viral markers
por: Kitagawa, Kosaku, et al.
Publicado: (2023)

Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2
por: Suzuki, Ryosuke, et al.
Publicado: (2013)

Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis
por: Suzuki, Takeshi, et al.
Publicado: (2022)

Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection
por: Kim, Kwang Su, et al.
Publicado: (2021)

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study
por: Ejima, Keisuke, et al.
Publicado: (2022)

Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
por: Miyakawa, Kei, et al.
Publicado: (2015)

SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV
por: Delobel, Diane, et al.
Publicado: (2022)

N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx
por: Murata, Takayuki, et al.
Publicado: (2023)

Cooperation Between Japan’s NIID and China CDC in Japan’s COVID-19 Response
por: Wakita, Takaji
Publicado: (2020)

The winner takes it all: how semelparous insects can become periodical
por: Diekmann, Odo, et al.
Publicado: (2019)

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
por: Gailhouste, Luc, et al.
Publicado: (2021)

Ethical Dilemmas Associated With the COVID-19 Pandemic: Dealing With the Unknowns and Unanswerables During Training
por: Han, Jason J., et al.
Publicado: (2020)

Anticoagulation dilemma in a high-risk patient with On-X valves
por: Karkar, Ami M., et al.
Publicado: (2015)

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus
por: Kitamura, Kouichi, et al.
Publicado: (2018)

Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression
por: Sun, Suofeng, et al.
Publicado: (2017)

Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection
por: Sakurai, Fuminori, et al.
Publicado: (2017)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes
por: Akahori, Yuichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8v01srnreebbsrpke22geu6vbj